Long-term therapy for pulmonary hypertension in children

Catherine L. Dent, J. Julio Pérez Fontán

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This review recounts recent advances in the understanding and treatment of the processes that cause pulmonary hypertension in infancy and childhood. New discoveries have begun to unveil connections between the basic physiological mechanisms responsible for the regulation of pulmonary vascular tone and the abnormal responses of the pulmonary vasculature in a variety of disease conditions, These discoveries raise hope for new therapeutic interventions that may improve the high mortality and morbidity of both children and adults with pulmonary vascular disease. In the meantime, treatment efforts continue to be focused on the relief of pulmonary vasoconstriction with inhaled nitric oxide and intravenous prostacyclin in the short term and oral calcium channel blockers as the mainstay of long-term therapy. Lung transplantation often remains as the only viable option for continued survival when the pulmonary vascular disease is progressive.

Original languageEnglish (US)
Pages (from-to)218-222
Number of pages5
JournalCurrent Opinion in Pediatrics
Volume11
Issue number3
DOIs
StatePublished - 1999

Fingerprint

Pulmonary Hypertension
Vascular Diseases
Lung
Lung Diseases
Lung Transplantation
Calcium Channel Blockers
Epoprostenol
Therapeutics
Vasoconstriction
Blood Vessels
Nitric Oxide
Morbidity
Mortality

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Long-term therapy for pulmonary hypertension in children. / Dent, Catherine L.; Pérez Fontán, J. Julio.

In: Current Opinion in Pediatrics, Vol. 11, No. 3, 1999, p. 218-222.

Research output: Contribution to journalArticle

@article{63060c11a96f419ab79650b272384720,
title = "Long-term therapy for pulmonary hypertension in children",
abstract = "This review recounts recent advances in the understanding and treatment of the processes that cause pulmonary hypertension in infancy and childhood. New discoveries have begun to unveil connections between the basic physiological mechanisms responsible for the regulation of pulmonary vascular tone and the abnormal responses of the pulmonary vasculature in a variety of disease conditions, These discoveries raise hope for new therapeutic interventions that may improve the high mortality and morbidity of both children and adults with pulmonary vascular disease. In the meantime, treatment efforts continue to be focused on the relief of pulmonary vasoconstriction with inhaled nitric oxide and intravenous prostacyclin in the short term and oral calcium channel blockers as the mainstay of long-term therapy. Lung transplantation often remains as the only viable option for continued survival when the pulmonary vascular disease is progressive.",
author = "Dent, {Catherine L.} and {P{\'e}rez Font{\'a}n}, {J. Julio}",
year = "1999",
doi = "10.1097/00008480-199906000-00008",
language = "English (US)",
volume = "11",
pages = "218--222",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Long-term therapy for pulmonary hypertension in children

AU - Dent, Catherine L.

AU - Pérez Fontán, J. Julio

PY - 1999

Y1 - 1999

N2 - This review recounts recent advances in the understanding and treatment of the processes that cause pulmonary hypertension in infancy and childhood. New discoveries have begun to unveil connections between the basic physiological mechanisms responsible for the regulation of pulmonary vascular tone and the abnormal responses of the pulmonary vasculature in a variety of disease conditions, These discoveries raise hope for new therapeutic interventions that may improve the high mortality and morbidity of both children and adults with pulmonary vascular disease. In the meantime, treatment efforts continue to be focused on the relief of pulmonary vasoconstriction with inhaled nitric oxide and intravenous prostacyclin in the short term and oral calcium channel blockers as the mainstay of long-term therapy. Lung transplantation often remains as the only viable option for continued survival when the pulmonary vascular disease is progressive.

AB - This review recounts recent advances in the understanding and treatment of the processes that cause pulmonary hypertension in infancy and childhood. New discoveries have begun to unveil connections between the basic physiological mechanisms responsible for the regulation of pulmonary vascular tone and the abnormal responses of the pulmonary vasculature in a variety of disease conditions, These discoveries raise hope for new therapeutic interventions that may improve the high mortality and morbidity of both children and adults with pulmonary vascular disease. In the meantime, treatment efforts continue to be focused on the relief of pulmonary vasoconstriction with inhaled nitric oxide and intravenous prostacyclin in the short term and oral calcium channel blockers as the mainstay of long-term therapy. Lung transplantation often remains as the only viable option for continued survival when the pulmonary vascular disease is progressive.

UR - http://www.scopus.com/inward/record.url?scp=0033027723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033027723&partnerID=8YFLogxK

U2 - 10.1097/00008480-199906000-00008

DO - 10.1097/00008480-199906000-00008

M3 - Article

VL - 11

SP - 218

EP - 222

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 3

ER -